10-hypertension-anti hypertensive agent.pdf
10-hypertension-anti hypertensive agents.pdf
100-venous thrombosis-fibrinolysis.pdf
101-venous thrombosis-antithrombotics.pdf
102-pulmonary embolism-antithrombotics.pdf
103-venous thrombosis-antithrombotics.pdf
104-heart failure-resynchronization (CRT) - defibrillators (ICD).pdf
105-heart failure-resynchronization (CRT) - defibrillators (ICD).pdf
106-heart failure-resynchronization (CRT) - defibrillators (ICD).pdf
107-prevention of sudden death-resynchronization (CRT) - defibrillators (ICD).pdf
108-prevention of sudden death-resynchronization (CRT) - defibrillators (ICD).pdf
109-prevention of sudden death-resynchronization (CRT) - defibrillators (ICD).pdf
11-cardiovascular prevention-cholesterol lowering intervention.pdf
110-pulmonary embolism-fibrinolysis.pdf
112-atrial fibrillation-rythm control.pdf
113-atrial fibrillation-antiarrythmic drugs.pdf
117-heart failure-phosphodiesterase III inhibitors .pdf
118-stable angina-HR-slowing agents.pdf
119-heart failure-beta-blockers.pdf
12-cardiovascular prevention-cholesterol lowering intervention.pdf
120-cardiovascular prevention-antithrombotics.pdf
121-cardiovascular prevention-omega-3 fatty acids .pdf
122-venous thrombosis-caval filter.pdf
123-cardiovascular prevention-omega-3 fatty acids .pdf
124-cardiovascular prevention-omega-3 fatty acids .pdf
125-hypertension-angiotensin-receptor blockers.pdf
126-cardiovascular prevention-cholesterol lowering intervention.pdf
127-cardiovascular prevention-plasma homocysteine lowering intervention.pdf
129-acute myocardial infarction-myocardial revascularization.pdf
13-hypertension-anti hypertensive agent.pdf
13-hypertension-anti hypertensive agents.pdf
130-acute myocardial infarction-antiarrythmic drugs.pdf
131-cardiovascular prevention-antioxydants.pdf
132-cardiovascular prevention-antithrombotics.pdf
133-acute myocardial infarction-myocardial revascularization.pdf
134-acute myocardial infarction-Late revascularisation.pdf
135-acute myocardial infarction-myocardial revascularization.pdf
136-familial hypercholesterolemia -cholesterol lowering intervention.pdf
137-cardiovascular prevention-cholesterol lowering intervention.pdf
139-progression of atherosclerosis-cholesterol lowering intervention.pdf
14-hypertension-anti hypertensive agent.pdf
14-hypertension-anti hypertensive agents.pdf
140-progression of atherosclerosis-cholesterol lowering intervention.pdf
141-acute myocardial infarction-calcium channel blockers.pdf
142-acute myocardial infarction-calcium channel blockers.pdf
143-acute myocardial infarction-calcium channel blockers.pdf
144-acute myocardial infarction-nitrates.pdf
145-acute myocardial infarction-angiotensin-Converting Enzyme Inhibitors.pdf
146-acute myocardial infarction-angiotensin-Converting Enzyme Inhibitors.pdf
147-acute myocardial infarction-angiotensin-Converting Enzyme Inhibitors.pdf
148-percutaneous coronary intervention-statin.pdf
148-percutaneous coronary intervention-statins.pdf
149-venous thrombosis-antithrombotics.pdf
15-heart failure-resynchronization (CRT) - defibrillators (ICD).pdf
150-DVT prophylaxis-antithrombotics.pdf
150-thrombosis prevention-antithrombotics.pdf
152-percutaneous coronary intervention-antithrombotics.pdf
153-post stroke-cholesterol lowering intervention.pdf
154-cardiovascular prevention-cholesterol lowering intervention.pdf
155-cardiovascular prevention-cholesterol lowering intervention.pdf
156-abdominal aortic aneurysm-agents to slow down human AAA-expansion.pdf
158-DVT prophylaxis-graduated compression stockings.pdf
158-thrombosis prevention-graduated compression stockings.pdf
160-percutaneous coronary intervention-pre treatment for PCI.pdf
161-atrioventricular block or sick sinus syndrome-pacemaker.pdf
162-acute myocardial infarction-cholesterol lowering intervention.pdf
163-carotid stenosis-endarterectomy.pdf
164-carotid stenosis-endovascular treatment.pdf
165-acute coronary syndrome-myocardial revascularization.pdf
167-acute coronary syndrome-anticoagulant.pdf
168-acute coronary syndrome-anticoagulant.pdf
169-acute coronary syndrome-antiplatelets drug.pdf
170-acute coronary syndrome-antiplatelets drug.pdf
171-acute coronary syndrome-heparin (UFH or LMWH).pdf
172-acute myocardial infarction-anticoagulant.pdf
173-post myocardial infarction-anticoagulant.pdf
175-patients at high risk for cardiovascular events-angiotensin-receptor blockers.pdf
176-heart failure-cholesterol lowering intervention.pdf
177-post myocardial infarction-primary prevention of sudden death.pdf
178-prevention of sudden death-antiarrythmic drugs.pdf
179-prevention of sudden death-antiarrythmic drugs.pdf
180-prevention of sudden death-ICD .pdf
181-prevention of sudden death-ICD .pdf
182-cardiac arrest-antiarrythmic drugs.pdf
183-prevention of sudden death-ICD .pdf
184-DVT prophylaxis-anticoagulant.pdf
184-thrombosis prevention-anticoagulant.pdf
185-DVT prophylaxis-direct antithrombins.pdf
185-thrombosis prevention-direct antithrombins.pdf
186-DVT prophylaxis-antiplatelets drug.pdf
186-thrombosis prevention-antiplatelets drug.pdf
187-DVT prophylaxis-direct factor Xa inhibitors.pdf
187-thrombosis prevention-direct factor Xa inhibitors.pdf
188-DVT prophylaxis-pentasaccharide.pdf
188-thrombosis prevention-pentasaccharide.pdf
189-DVT prophylaxis-heparin (UFH or LMWH).pdf
189-thrombosis prevention-heparin (UFH or LMWH).pdf
19-hypertension-anti hypertensive agent.pdf
19-hypertension-anti hypertensive agents.pdf
190-thrombosis prevention-LMWH.pdf
191-thrombosis prevention-UFH.pdf
192-thrombosis prevention-UFH.pdf
193-thrombosis prevention-UFH.pdf
194-thrombosis prevention-UFH.pdf
195-DVT prophylaxis-heparin (UFH or LMWH).pdf
195-thrombosis prevention-heparin (UFH or LMWH).pdf
196-thrombosis prevention-LMWH.pdf
197-DVT prophylaxis-heparin (UFH or LMWH).pdf
197-thrombosis prevention-heparin (UFH or LMWH).pdf
198-thrombosis prevention-LMWH.pdf
199-DVT prophylaxis-heparin (UFH or LMWH).pdf
199-thrombosis prevention-heparin (UFH or LMWH).pdf
20-hypertension-anti hypertensive agent.pdf
20-hypertension-anti hypertensive agents.pdf
200-thrombosis prevention-LMWH.pdf
201-DVT prophylaxis-heparin (UFH or LMWH).pdf
201-thrombosis prevention-heparin (UFH or LMWH).pdf
202-thrombosis prevention-LMWH.pdf
203-venous thrombosis-LMWH.pdf
204-venous thrombosis-heparin (UFH or LMWH).pdf
206-coronary artery disease-Drug eluting stent.pdf
207-coronary artery disease-Drug eluting stent.pdf
208-coronary artery disease-Drug eluting stent.pdf
209-coronary artery disease-Drug eluting stent.pdf
21-acute coronary syndrome-cholesterol lowering intervention.pdf
210-coronary artery disease-Drug eluting stent.pdf
211-coronary artery disease-Drug eluting stent.pdf
212-coronary artery disease-Drug eluting stent.pdf
213-DVT prophylaxis-pentasaccharide.pdf
213-thrombosis prevention-pentasaccharide.pdf
214-coronary artery disease-Drug eluting stent.pdf
215-coronary artery disease-Drug eluting stent.pdf
216-coronary artery disease-Drug eluting stent.pdf
217-coronary artery disease-Drug eluting stent.pdf
218-superficial thrombophlebitis-antithrombotics.pdf
22-acute coronary syndrome-myocardial revascularization.pdf
220-cardiovascular prevention-antiplatelets drug.pdf
221-diabetes type 2-antiplatelets drug.pdf
222-acute coronary syndrome-calcium channel blockers.pdf
223-acute coronary syndrome-fibrinolysis.pdf
224-acute coronary syndrome-nitrates.pdf
225-CABG surgery-antiplatelets drug.pdf
226-cardiovascular prevention-antiplatelets drug.pdf
227-cardiovascular prevention-antithrombotics.pdf
228-diabetes type 2-antithrombotics.pdf
229-peripheral vascular diseases-antioxydants.pdf
230-peripheral vascular diseases-antioxydants.pdf
231-diabetes type 2-antioxydants.pdf
232-cardiovascular prevention-antioxydants.pdf
233-heart failure-angiotensin-receptor blockers.pdf
234-heart failure-inhibition of the renin-angiotensin system (ACEI or ARB).pdf
235-heart failure-angiotensin-Converting Enzyme Inhibitors.pdf
236-heart failure-diuretics.pdf
237-heart failure with preserved LVEF -All mechanism.pdf
238-heart failure-angiotensin-Converting Enzyme Inhibitors.pdf
239-cardiac arrest-fibrinolysis.pdf
24-acute coronary syndrome-antithrombotics.pdf
240-diabetes type 2-intensive glycemic control .pdf
241-cardiovascular prevention-cholesterol lowering intervention.pdf
242-heart failure-vasopressin antagonist.pdf
243-heart failure-vasopeptidase inhibitor.pdf
246-acute myocardial infarction-PCI.pdf
248-acute myocardial infarction-myocardial revascularization.pdf
249-acute myocardial infarction-myocardial revascularization.pdf
25-stable angina-myocardial revascularization.pdf
250-acute myocardial infarction-glucose insulin potassium.pdf
251-post myocardial infarction-antiarrythmic drugs.pdf
252-post myocardial infarction-calcium channel blockers.pdf
253-acute myocardial infarction-angiotensin-receptor blockers.pdf
254-acute myocardial infarction-myocardial revascularization.pdf
255-acute myocardial infarction-PCI.pdf
256-acute myocardial infarction-myocardial revascularization.pdf
257-acute myocardial infarction-PCI.pdf
259-acute myocardial infarction-PCI.pdf
26-coronary artery disease-myocardial revascularization.pdf
260-acute myocardial infarction-fibrinolysis.pdf
261-acute myocardial infarction-fibrinolysis.pdf
262-stable angina-HR-slowing agents.pdf
263-stable angina-anti-anginal drugs.pdf
264-acute coronary syndrome-anti-anginal drugs.pdf
265-obesity and overweight-All mechanism.pdf
267-diabetes type 2-intensive glycemic control .pdf
268-diabetes type 2-intensive glycemic control .pdf
269-atrial fibrillation-antiarrythmic drugs.pdf
27-stable angina-myocardial revascularization.pdf
270-cardiac arrest-vasopressin.pdf
271-heart failure-BNP guided management .pdf
272-carotid stenosis-endarterectomy.pdf
273-atrial fibrillation-antiarrythmic drugs.pdf
274-coronary artery disease-transmyocardial revacularization.pdf
275-cardiovascular prevention-antiplatelets drug.pdf
276-cardiovascular prevention-antiplatelets drug.pdf
277-post myocardial infarction-antiplatelets drug.pdf
278-peripheral vascular diseases-antiplatelets drug.pdf
28-stable angina-myocardial revascularization.pdf
280-carotid stenosis-endovascular treatment.pdf
281-hypertension-anti hypertensive agent.pdf
281-hypertension-anti hypertensive agents.pdf
282-cardiovascular prevention-lifestyle intervention.pdf
283-post myocardial infarction-omega-3 fatty acids .pdf
284-cardiovascular prevention-cholesterol lowering intervention.pdf
285-diabetes type 2-screening for CAD .pdf
287-heart failure-relaxine.pdf
288-restenosis after PCI-Intravascular Brachytherapy.pdf
289-DVT prophylaxis-antithrombotics.pdf
289-thrombosis prevention-antithrombotics.pdf
29-stable angina-myocardial revascularization.pdf
291-percutaneous coronary intervention-antithrombotics.pdf
292-acute myocardial infarction-cell-based therapies .pdf
293-heart failure-vasopressin antagonist.pdf
294-heart failure-new drug under development.pdf
295-acute myocardial infarction-new drug under development.pdf
296-CABG surgery-preconditioning .pdf
298-acute myocardial infarction-new drug under development.pdf
299-coronary artery disease-cell-based therapies .pdf
30-coronary artery disease-myocardial revascularization.pdf
300-coronary artery disease-cell-based therapies .pdf
301-heart failure-increasing hemoglobin concentration .pdf
302-percutaneous coronary intervention-anti inflammatory drugs.pdf
303-acute myocardial infarction-complement inhibition.pdf
304-acute myocardial infarction-complement inhibition.pdf
305-cardiovascular prevention-omega-3 fatty acids .pdf
306-cardiac arrest-omega-3 fatty acids .pdf
307-restenosis after PCI-new drug under development.pdf
308-acute myocardial infarction-heparin (UFH or LMWH).pdf
309-hypertension-renin inhibitor .pdf
31-coronary artery disease-myocardial revascularization.pdf
310-hypertension-renin inhibitor .pdf
311-heart failure-renin inhibitor .pdf
312-heart failure-anti inflammatory drugs.pdf
313-acute myocardial infarction-cell-based therapies .pdf
314-heart failure-diuretics.pdf
315-CABG surgery-off-pump CABG.pdf
316-acute myocardial infarction-PCI.pdf
317-acute myocardial infarction-myocardial revascularization.pdf
318-percutaneous coronary intervention-restenosis prevention.pdf
319-heart failure-renin inhibitor .pdf
32-coronary artery disease-myocardial revascularization.pdf
320-atrial fibrillation-catheter ablation .pdf
321-diabetes type 2-insulin sensitizers - glitazones.pdf
322-cardiovascular prevention-antiplatelets drug.pdf
323-stent-antiplatelets drug.pdf
326-cardiovascular prevention-niacin.pdf
328-atrial fibrillation-prevention.pdf
33-stable angina-antithrombotics.pdf
330-heart failure-Exercise Therapy.pdf
331-atrial fibrillation-prevention.pdf
335-peripheral vascular diseases-cell-based therapies .pdf
336-hypertension-intensive blood pressure control.pdf
337-atrial fibrillation-embolic protection.pdf
338-CABG surgery-vein grafts pretreatment.pdf
339-cardiovascular prevention-ACAT inhibition.pdf
34-stable angina-antibiotics.pdf
340-cardiovascular prevention-CEPT inhibition.pdf
341-diabetes type 2-prevention.pdf
342-impaired fasting glucose -prevention.pdf
343-hypertension-intensive blood pressure control.pdf
344-hypertension-intensive blood pressure control.pdf
345-acute coronary syndrome-direct factor Xa inhibitors.pdf
346-acute coronary syndrome-antiplatelets drug.pdf
347-acute coronary syndrome-antithrombotics.pdf
348-acute coronary syndrome-antithrombotics.pdf
349-heart failure-resynchronization (CRT) - defibrillators (ICD).pdf
35-acute coronary syndrome-antithrombotics.pdf
350-acute myocardial infarction-thrombectomy.pdf
351-coronary artery disease-anti-anginal drugs.pdf
352-acute myocardial infarction-percutaneous left ventricular assist devices.pdf
353-acute myocardial infarction-ICD .pdf
354-percutaneous coronary intervention-radial access.pdf
355-percutaneous coronary intervention-thrombectomy.pdf
356-abdominal aortic aneurysm-endovascular treatment.pdf
357-percutaneous coronary intervention-proton-pump inhibitors.pdf
358-stable angina-spinal cord stimulation.pdf
359-coronary artery disease-anti-anginal drugs.pdf
36-acute myocardial infarction-antithrombotics.pdf
360-percutaneous coronary intervention-anti-anginal drugs.pdf
362-diabetes type 2-antiplatelets drug.pdf
363-post acute coronary syndromes -antithrombotics.pdf
364-post myocardial infarction-antithrombotics.pdf
365-heart failure-percutaneous left ventricular assist devices.pdf
366-cardiac arrest-Public Access Defibrillation .pdf
367-throracic aortic aneuvrism-endovascular treatment.pdf
368-atrial fibrillation-direct antithrombins.pdf
369-DVT prophylaxis-direct antithrombins.pdf
369-thrombosis prevention-direct antithrombins.pdf
37-DVT prophylaxis-antithrombotics.pdf
37-thrombosis prevention-antithrombotics.pdf
370-venous thrombosis-direct antithrombins.pdf
371-DVT prophylaxis-direct factor Xa inhibitors.pdf
371-thrombosis prevention-direct factor Xa inhibitors.pdf
372-venous thrombosis-direct factor Xa inhibitors.pdf
373-atrial fibrillation-direct factor Xa inhibitors.pdf
374-hypertension-anti hypertensive agent.pdf
374-hypertension-anti hypertensive agents.pdf
376-diabetes type 2-insulin sensitizers - glitazones.pdf
377-diabetes type 2-insulin sensitizer.pdf
378-diabetes type 2-insulin sensitizer.pdf
379-diabetes type 2-alpha-glucosidase inhibitors .pdf
38-DVT prophylaxis-antithrombotics.pdf
38-thrombosis prevention-antithrombotics.pdf
380-DVT prophylaxis-pentasaccharide.pdf
380-thrombosis prevention-pentasaccharide.pdf
381-diabetes type 2-insulin secretagogues peptides (incretins).pdf
383-patients with implantable cardioverter defibrillators -omega-3 fatty acids .pdf
384-patients with implantable cardioverter defibrillators -catheter ablation .pdf
385-aortic stenosis-cholesterol lowering intervention.pdf
386-DVT prophylaxis-antithrombotics.pdf
386-thrombosis prevention-antithrombotics.pdf
387-acute coronary syndrome-antithrombotics.pdf
388-percutaneous coronary intervention-anticoagulant.pdf
389-percutaneous coronary intervention-antiplatelets drug.pdf
39-DVT prophylaxis-antithrombotics.pdf
39-thrombosis prevention-antithrombotics.pdf
390-acute myocardial infarction-antiplatelets drug.pdf
391-atrial fibrillation-direct oral anticoagulant (DAO).pdf
392-atrial fibrillation-antithrombotics.pdf
393-DVT prophylaxis-direct oral anticoagulant (DAO).pdf
393-thrombosis prevention-direct oral anticoagulant (DAO).pdf
394-DVT prophylaxis-direct oral anticoagulant (DAO).pdf
394-thrombosis prevention-direct oral anticoagulant (DAO).pdf
395-DVT prophylaxis-direct oral anticoagulant (DAO).pdf
395-thrombosis prevention-direct oral anticoagulant (DAO).pdf
396-DVT prophylaxis-pentasaccharide.pdf
396-thrombosis prevention-pentasaccharide.pdf
40-DVT prophylaxis-antithrombotics.pdf
40-thrombosis prevention-antithrombotics.pdf
400-atrial fibrillation-rate control.pdf
401-CABG surgery-radial graft.pdf
402-DVT prophylaxis-mechanical devices for thromboprophylaxis.pdf
402-thrombosis prevention-mechanical devices for thromboprophylaxis.pdf
403-cardiovascular prevention-antiplatelets drug.pdf
404-hypertension-anti hypertensive agent.pdf
404-hypertension-anti hypertensive agents.pdf
405-DVT prophylaxis-antithrombotics.pdf
405-thrombosis prevention-antithrombotics.pdf
406-DVT prophylaxis-antithrombotics.pdf
406-thrombosis prevention-antithrombotics.pdf
407-hypertension-antiplatelets drug.pdf
408-diabetes type 2-antidiabetic drugs added to metformin.pdf
409-diabetes type 2-insulin secretagogues.pdf
41-acute myocardial infarction-beta-blockers.pdf
410-post stroke-anti hypertensive agent.pdf
410-post stroke-anti hypertensive agents.pdf
411-post stroke-antiplatelets drug.pdf
413-post stroke-anticoagulant.pdf
414-diabetes type 2-anti hypertensive agent.pdf
414-diabetes type 2-anti hypertensive agents.pdf
415-diabetes type 2-anti hypertensive agent.pdf
415-diabetes type 2-anti hypertensive agents.pdf
416-diabetes type 2-prevention.pdf
418-cardiovascular prevention-polypill.pdf
419-abdominal aortic aneurysm-endovascular treatment.pdf
42-acute myocardial infarction-beta-blockers.pdf
420-abdominal aortic aneurysm-endovascular treatment.pdf
421-post stroke-prevention.pdf
422-coronary artery disease-Drug eluting stent.pdf
423-post acute coronary syndromes -antioxydants.pdf
424-post myocardial infarction-antioxydants.pdf
425-miscellaneous-angiotensin-receptor blockers.pdf
427-diabetes type 2-angiotensin-receptor blockers.pdf
428-acute coronary syndrome-oxygen therapy.pdf
429-acute myocardial infarction-oxygen therapy.pdf
43-heart failure-angiotensin-Converting Enzyme Inhibitors.pdf
430-post stroke-foramen ovale closure .pdf
432-cardiovascular prevention-antioxydants.pdf
433-cardiovascular prevention-antioxydants.pdf
434-cardiovascular prevention-antioxydants.pdf
435-cardiovascular prevention-cholesterol lowering intervention.pdf
436-postthrombotic syndrome-prevention.pdf
437-cardiovascular prevention-antithrombotics.pdf
438-diabetes type 2-angiotensin renin system blockade.pdf
439-cardiac arrest-compression-only CPR.pdf
44-heart failure-beta-blockers.pdf
440-cardiovascular prevention-plasma homocysteine lowering intervention.pdf
441-cardiovascular prevention-plasma homocysteine lowering intervention.pdf
443-cardiovascular prevention-weight-loss drugs.pdf
444-cardiovascular prevention-weight-loss drugs.pdf
445-cardiovascular prevention-weight-loss drugs.pdf
446-diabetes type 2-weight-loss drugs.pdf
447-cardiovascular prevention-lifestyle intervention.pdf
448-cardiovascular prevention-lifestyle intervention.pdf
449-post myocardial infarction-secondary prevention.pdf
45-post myocardial infarction-cholesterol lowering intervention.pdf
450-coronary artery disease-death and events prevention.pdf
451-cardiovascular prevention-plasma homocysteine lowering intervention.pdf
452-cardiovascular prevention-hormonal replacement therapy.pdf
453-cardiovascular prevention-hormonal replacement therapy.pdf
454-cardiovascular prevention-hormonal replacement therapy.pdf
455-acute coronary syndrome-New P2Y12 Inhibitors.pdf
456-heart failure-HR-slowing agents.pdf
457-percutaneous coronary intervention-anticoagulant.pdf
458-hypertension-cholesterol lowering intervention.pdf
459-diabetes type 2-intensive therapy.pdf
46-heart failure-antiarrythmic drugs.pdf
460-heart failure-Miscellaneous.pdf
461-DVT prophylaxis-antiplatelets drug.pdf
461-thrombosis prevention-antiplatelets drug.pdf
462-DVT prophylaxis-antiplatelets drug.pdf
462-thrombosis prevention-antiplatelets drug.pdf
463-DVT prophylaxis-antiplatelets drug.pdf
463-thrombosis prevention-antiplatelets drug.pdf
464-DVT prophylaxis-antiplatelets drug.pdf
464-thrombosis prevention-antiplatelets drug.pdf
465-DVT prophylaxis-mechanical devices for thromboprophylaxis.pdf
465-thrombosis prevention-mechanical devices for thromboprophylaxis.pdf
466-DVT prophylaxis-mechanical devices for thromboprophylaxis.pdf
466-thrombosis prevention-mechanical devices for thromboprophylaxis.pdf
469-percutaneous coronary intervention-antithrombotics.pdf
47-Head and neck cancer-Induction chemotherapy.pdf
470-acute myocardial infarction-increasing hemoglobin concentration.pdf
471-heart failure-telemonitoring.pdf
472-heart failure-vasodilators therapy.pdf
475-DVT prophylaxis-direct oral anticoagulant (DAO).pdf
475-thrombosis prevention-direct oral anticoagulant (DAO).pdf
479-diabetes type 2-SGLT2 inhibitors.pdf
48-Head and neck cancer-Induction chemotherapy.pdf
480-acute coronary syndrome-direct oral anticoagulant (DAO).pdf
481-cardiovascular prevention-anticoagulant.pdf
482-aortic stenosis-transcatheter aortic-valve implantation (TAVI).pdf
483-diabetes type 2-insulin secretagogues - sulfonylureas.pdf
484-cardiac arrest-active compression-decompression CPR.pdf
485-DVT prophylaxis-direct oral anticoagulant (DAO).pdf
485-thrombosis prevention-direct oral anticoagulant (DAO).pdf
486-early breast cancer -monoclonal antibody.pdf
488-heart failure-aldosterone blockade .pdf
489-cardiac arrest-modified resuscitation protocol.pdf
49-peripheral vascular diseases-vasodilators therapy.pdf
490-diabetes type 2-insulin secretagogues peptides (incretins).pdf
495-hypertension-intensive blood pressure control.pdf
496-hypertension-angioplasty.pdf
5-cardiovascular prevention-cholesterol lowering intervention.pdf
50-peripheral vascular diseases-antithrombotics.pdf
501-stable angina-myocardial revascularization.pdf
502-coronary artery disease-myocardial revascularization.pdf
503-cardiovascular prevention-HDL increasing drugs.pdf
505-venous thrombosis-direct oral anticoagulant (DAO).pdf
509-diabetes type 2-antidiabetic drugs.pdf
51-peripheral vascular diseases-Exercise Therapy.pdf
510-diabetes type 2-antidiabetic drugs.pdf
511-diabetes type 2-antidiabetic drugs.pdf
512-diabetes type 2-antidiabetic drugs.pdf
513-diabetes type 2-antidiabetic drugs.pdf
514-atrial fibrillation-antiarrythmic drugs.pdf
515-heart failure-cell-based therapies .pdf
518-cardiovascular prevention-dietary salt reduction.pdf
519-cardiovascular prevention-dietary salt reduction.pdf
52-peripheral vascular diseases-cholesterol lowering intervention.pdf
520-cardiovascular prevention-dietary salt reduction.pdf
535-left ventricular dysfunction after myocardial infarction-All mechanism.pdf
544-diabetes type 2-antidiabetic drugs.pdf
545-diabetes type 2-antidiabetic drugs.pdf
546-diabetes type 2-antidiabetic drugs.pdf
547-diabetes type 2-antidiabetic drugs.pdf
548-diabetes type 2-insulin therapy.pdf
549-diabetes type 2-insulin secretagogues - Meglitinides (glinides).pdf
550-diabetes type 2-insulin secretagogues - DPP-4 inhibitors.pdf
551-diabetes type 2-insulin sensitizer - biguanides.pdf
552-diabetes type 2-insulin sensitizers - PPAR modulator.pdf
562-acute myocardial infarction-percutaneous left ventricular assist device .pdf
563-coronary artery disease-fractional-flow-reserve-guided PCI.pdf
564-acute coronary syndrome-antiplatelets drug.pdf
565-atrial fibrillation-antithrombotics.pdf
566-percutaneous coronary intervention-antiplatelets drug.pdf
568-cardiovascular prevention-diet.pdf
57-atrial fibrillation-antithrombotics.pdf
576-diabetes type 2-glucose lowering for cardiovascular prevention.pdf
578-stent-dual antiplatelet therapy .pdf
579-melanoma-All mechanism.pdf
580-melanoma-All mechanism.pdf
581-melanoma-All mechanism.pdf
582-lung cancer (metastatic)-immune checkpoint inhibition.pdf
582-lung cancer-immune checkpoint inhibition.pdf
583-multiple myeloma-All mechanism.pdf
584-multiple myeloma-All mechanism.pdf
587-advanced breast cancer (metastatic)-mTOR inhibitor .pdf
588-advanced breast cancer (metastatic)-Taxanes.pdf
589-advanced breast cancer (metastatic)-multi target TKI.pdf
590-advanced breast cancer (metastatic)-CDK (cyclin-dependent kinase) inhibitor.pdf
590-advanced breast cancer (metastatic)-cyclin inhibitors .pdf
591-advanced breast cancer (metastatic)-LHRH agonist.pdf
592-advanced breast cancer (metastatic)-aromatase inhibitors.pdf
594-advanced breast cancer (metastatic)- selective estrogen receptor modulator (SERM).pdf
595-advanced breast cancer (metastatic)-angiogenesis inhibitors.pdf
598-advanced breast cancer (metastatic)-monoclonal antibody.pdf
599-cardiovascular prevention-PCSK9 Inhibitors.pdf
6-cardiovascular prevention-cholesterol lowering intervention.pdf
601-advanced breast cancer (metastatic)-histone deacetylase (HDAC) inhibitors.pdf
602-advanced breast cancer (metastatic)-AKT Inhibitors.pdf
603-advanced breast cancer (metastatic)-Phosphoinositide 3-kinase inhibitor.pdf
604-advanced breast cancer (metastatic)-HER2 inhibitors.pdf
605-advanced breast cancer (metastatic)-nontaxane microtubule dynamics inhibitor .pdf
606-advanced breast cancer (metastatic)-Selective estrogen receptor downregulators (SERDs).pdf
607-advanced breast cancer (metastatic)-high dose chemotherapy.pdf
608-advanced breast cancer (metastatic)-combination chemotherapy with platinum salts.pdf
609-advanced breast cancer (metastatic)-Capecitabine containing-regimen.pdf
610-advanced breast cancer (metastatic)-Gemcitabine containg regimen.pdf
611-advanced breast cancer (metastatic)-Vinorelbine containing regimen.pdf
612-advanced breast cancer (metastatic)-maintenance chemotherapy.pdf
613-advanced breast cancer (metastatic)-ixabepilone based chemotherapy.pdf
614-advanced breast cancer (metastatic)-Anthracyclines based regimen.pdf
615-advanced breast cancer (metastatic)-Selective estrogen receptor downregulators (SERDs).pdf
616-advanced breast cancer (metastatic)-Selective estrogen receptor downregulators (SERDs).pdf
617-advanced breast cancer (metastatic)-mTOR inhibitor .pdf
618-advanced breast cancer (metastatic)-mTOR inhibitor .pdf
619-advanced breast cancer (metastatic)-mTOR inhibitor .pdf
62-acute coronary syndrome-antithrombotics.pdf
620-advanced breast cancer (metastatic)-angiogenesis inhibitors.pdf
621-advanced breast cancer (metastatic)-angiogenesis inhibitors.pdf
622-advanced breast cancer (metastatic)-locoregional treatment of the primary tumor.pdf
623-melanoma-Immunotherapy .pdf
624-lung cancer (metastatic)-angiogenesis inhibitors.pdf
624-lung cancer-angiogenesis inhibitors.pdf
625-lung cancer (metastatic)-EGFR inhibitors .pdf
625-lung cancer-EGFR inhibitors .pdf
627-lung cancer (metastatic)-Taxanes.pdf
628-advanced renal-cell carcinoma-multi target TKI.pdf
628-renal-cell carcinoma (advanced)-multi target TKI.pdf
629-advanced renal-cell carcinoma-Immunotherapy .pdf
629-renal-cell carcinoma (advanced)-Immunotherapy .pdf
629-renal-cell carcinoma (advanced)-interferon.pdf
63-percutaneous coronary intervention-antithrombotics.pdf
630-advanced renal-cell carcinoma-mTOR inhibitor .pdf
630-renal-cell carcinoma (advanced)-mTOR inhibitor .pdf
631-advanced renal-cell carcinoma-All mechanism.pdf
631-renal-cell carcinoma (advanced)-All mechanism.pdf
632-advanced renal-cell carcinoma-angiogenesis inhibitors.pdf
632-renal-cell carcinoma (advanced)-angiogenesis inhibitors.pdf
633-advanced renal-cell carcinoma-All mechanism.pdf
633-renal-cell carcinoma (advanced)-All mechanism.pdf
636-multiple myeloma-All mechanism.pdf
637-heart failure-combined inhibition of ACE and neprilysin.pdf
638-lung cancer (metastatic)-chemotherapy.pdf
638-lung cancer-chemotherapy.pdf
639-acute heart failure-diuretics.pdf
64-acute myocardial infarction-antithrombotics.pdf
640-acute heart failure-new drug under development.pdf
641-acute heart failure-vasodilators therapy.pdf
642-acute heart failure-vasopressin antagonist.pdf
643-acute heart failure-endothelin receptor antagonist .pdf
644-acute heart failure-atrial natriuretic peptide .pdf
645-acute heart failure-positive inotropic agent .pdf
646-acute heart failure-relaxin.pdf
647-acute heart failure-calcium sensitiser.pdf
648-acute heart failure-ultrafiltration.pdf
649-heart failure-regenerative therapy.pdf
65-heart failure-angiotensin-receptor blockers.pdf
650-lung cancer (metastatic)-immune checkpoint inhibition.pdf
650-lung cancer-immune checkpoint inhibition.pdf
652-acute coronary syndrome-antiplatelets drug.pdf
654-advanced breast cancer (metastatic)-AKT Inhibitors.pdf
655-advanced breast cancer (metastatic)-multi target TKI.pdf
656-advanced breast cancer (metastatic)-CDK (cyclin-dependent kinase) inhibitor.pdf
656-advanced breast cancer (metastatic)-cyclin inhibitors .pdf
657-advanced breast cancer (metastatic)-histone deacetylase (HDAC) inhibitors.pdf
658-advanced breast cancer (metastatic)-mTOR inhibitor .pdf
659-advanced breast cancer (metastatic)-Phosphoinositide 3-kinase inhibitor.pdf
66-heart failure-angiotensin-receptor blockers.pdf
660-advanced breast cancer (metastatic)-HER2 inhibitors.pdf
661-peripheral vascular diseases-antithrombotics.pdf
662-peripheral vascular diseases-anticoagulant.pdf
663-cardiovascular prevention-antithrombotics.pdf
664-heart failure-Miscellaneous.pdf
665-heart failure-mineralocorticoid receptor antagonists .pdf
666-heart failure-mineralocorticoid receptor antagonists .pdf
667-diabetic kidney disease-All mechanism.pdf
668-percutaneous coronary intervention-bioresorbable vascular scaffold.pdf
669-lung cancer (metastatic)-ALK inhibitors.pdf
669-lung cancer-ALK inhibitors.pdf
67-heart failure-angiotensin-receptor blockers.pdf
670-advanced breast cancer (metastatic)-immune checkpoint inhibition.pdf
671-advanced breast cancer (metastatic)-FGFR inhibitors.pdf
672-advanced breast cancer (metastatic)-FGFR inhibitors.pdf
673-coronary artery disease-anticoagulant.pdf
675-advanced urothelial carcinoma-immune checkpoint inhibition.pdf
675-urothelial carcinoma (advanced)-immune checkpoint inhibition.pdf
676-advanced breast cancer (metastatic)-poly ADP-ribose polymerase (PARP) inhibitor.pdf
677-advanced breast cancer (metastatic)-poly ADP-ribose polymerase (PARP) inhibitor.pdf
678-early breast cancer -HER2 inhibitors.pdf
68-heart failure-angiotensin-receptor blockers.pdf
680-advanced breast cancer (metastatic)-poly ADP-ribose polymerase (PARP) inhibitor.pdf
681-ovarian cancer-poly ADP-ribose polymerase (PARP) inhibitor.pdf
682-venous thrombosis-antithrombotics.pdf
683-post acute coronary syndromes -anti inflammatory drugs.pdf
684-post myocardial infarction-anti inflammatory drugs.pdf
685-hypertension-anti hypertensive agents.pdf
686-hypertension-anti hypertensive agents.pdf
687-hypertension-anti hypertensive agents.pdf
688-cardiovascular prevention-statins.pdf
689-cardiovascular prevention-statins.pdf
690-Head and neck cancer-immune checkpoint inhibition.pdf
691-multiple myeloma-immune checkpoint inhibition.pdf
692-diabetes type 2-glucose lowering for cardiovascular prevention.pdf
693-hypertension-renal denervation.pdf
694-cardiovascular prevention-statins.pdf
695-cardiovascular prevention-statins.pdf
698-lung cancer (metastatic)-EGFR inhibitors .pdf
699-lung cancer (metastatic)-EGFR inhibitors .pdf
7-cardiovascular prevention-cholesterol lowering intervention.pdf
70-heart failure-calcium channel blockers.pdf
700-lung cancer (metastatic)-immune checkpoint inhibition.pdf
701-lung cancer (metastatic)-immune checkpoint inhibition.pdf
702-ovarian cancer-poly ADP-ribose polymerase (PARP) inhibitor.pdf
703-ovarian cancer-poly ADP-ribose polymerase (PARP) inhibitor.pdf
706-cardiovascular prevention-direct oral anticoagulant (DAO).pdf
707-cardiovascular prevention-direct factor Xa inhibitors.pdf
708-cardiovascular prevention-antiplatelets drug.pdf
709-cardiovascular prevention-anticoagulant.pdf
71-heart failure-angiotensin-Converting Enzyme Inhibitors.pdf
710-cardiovascular prevention-anticoagulant.pdf
711-advanced renal-cell carcinoma-immune checkpoint inhibition.pdf
711-renal-cell carcinoma (advanced)-immune checkpoint inhibition.pdf
712-melanoma-immune checkpoint inhibition.pdf
713-lung cancer (metastatic)-CDK (cyclin-dependent kinase) inhibitor.pdf
714-melanoma-immune checkpoint inhibition.pdf
715-melanoma-immune checkpoint inhibition.pdf
716-melanoma-immune checkpoint inhibition.pdf
718-melanoma-B-Raf enzyme inhibitors.pdf
719-thrombosis prevention-LMWH.pdf
72-heart failure-antithrombotics.pdf
720-diabetes type 2-cholesterol lowering intervention.pdf
721-diabetes type 2-cholesterol lowering intervention.pdf
722-cardiovascular prevention-on top statins.pdf
724-multiple myeloma-proteasome inhibitor.pdf
725-gastric or gastro-oesophageal junction cancer (advanced)-immune checkpoint inhibition.pdf
726-melanoma-combined BRAF-MEK inhibitors.pdf
727-melanoma-MEK inhibitor.pdf
728-melanoma-combined BRAF-MEK inhibitors.pdf
729-melanoma-All mechanism.pdf
73-heart failure-antithrombotics.pdf
730-melanoma-B-Raf enzyme inhibitors.pdf
733-melanoma-Miscellaneous.pdf
734-atrial fibrillation-anticoagulant after PCI.pdf
736-heart failure-anticoagulant.pdf
737-venous thrombosis-direct oral anticoagulant (DAO).pdf
738-heart failure-direct oral anticoagulant (DAO).pdf
74-heart failure-diuretics.pdf
75-heart failure-diuretics.pdf
76-heart failure-diuretics.pdf
77-heart failure-cholesterol lowering intervention.pdf
78-heart failure-digitalis glycosides.pdf
79-heart failure-vasodilators therapy.pdf
80-diabetes type 2-antidiabetic drugs.pdf
81-diabetes type 2-antidiabetic drugs.pdf
82-diabetes type 2-antidiabetic drugs.pdf
83-diabetes type 2-anti hypertensive agent.pdf
83-diabetes type 2-anti hypertensive agents.pdf
85-diabetes type 2-cholesterol lowering intervention.pdf
87-DVT prophylaxis-antithrombotics.pdf
87-thrombosis prevention-antithrombotics.pdf
88-heart failure-Exercise Therapy.pdf
89-CABG surgery-cholesterol lowering intervention.pdf
9-hypertension-anti hypertensive agent.pdf
9-hypertension-anti hypertensive agents.pdf
90-acute myocardial infarction-myocardial revascularization.pdf
92-DVT prophylaxis-antithrombotics.pdf
92-thrombosis prevention-antithrombotics.pdf
93-DVT prophylaxis-antithrombotics.pdf
93-thrombosis prevention-antithrombotics.pdf
94-DVT prophylaxis-antithrombotics.pdf
94-thrombosis prevention-antithrombotics.pdf
95-DVT prophylaxis-antithrombotics.pdf
95-thrombosis prevention-antithrombotics.pdf
96-DVT prophylaxis-antithrombotics.pdf
96-thrombosis prevention-antithrombotics.pdf
97-patients at high risk for cardiovascular events-angiotensin-receptor blockers.pdf
98-patients at high risk for cardiovascular events-angiotensin-Converting Enzyme Inhibitors.pdf
99-DVT prophylaxis-antithrombotics.pdf
99-thrombosis prevention-antithrombotics.pdf
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
